Trump administration enacts 100 percent tariff on Australian drug imports

The Trump administration enacted a 100 percent tariff on Australian drug imports on Thursday, while exempting biotech giant CSL from the duties on plasma-derived products. The administration aims to incentivize US production and reduce prices, allowing large firms 120 days to adjust before the tariff takes effect. Smaller companies have six months to comply with the new regulations.

Read more on The Age →